+
Site Tour

ESOC 2023: Meet the Expert: Marta Rubiera LAAO challenging case

Meet The Expert Session: A case-based debate: Which patients might benefit from left atrial appendage occlusion? Marta Rubiera shares her experience of a challenging LAAO case at ESOC 2023.

Related Videos

ESOC 2023: AF patient LAA case

TriClip - AVVS 1 year 1 minute Tricuspid - Video

Case Transmission | Tricuspid focus

Trending Controversies | AV Valves

LAAO Summit - Clinical impact of PDLs

LAAO Summit 2023: CT or no-CT?

LAAO Summit - Debate: Factor XI inhibitors

Case Parade | Tricuspid focus

LAAO Summit - Ideal vs suboptimal LAAO implant

TRENDING TOPICS

Navigating the Anatomy | Tricuspid focus

Navigating the Anatomy | Tricuspid focus

F. Maisano, V. Delgado, P. Denti, M. Taramasso

Review the Trends | Tricuspid focus

Review the Trends | Tricuspid focus

M. Metra, G. Leurent, D. Tchetche, T. Nestelberger, D. Cohen, M. Adamo

Case Transmission | Tricuspid focus

Case Transmission | Tricuspid focus

F. Maisano, M. I. Koerber, H. Dreger, R. Bekeredjian, K. K. Yeo, T. Matsumoto

CONNEXT


TV
RELATED RESOURCES

AV Valves Summit 2024 | Closing of Day 2

LAAO Summit - Device placement and DRT

Irie's testimonial

LAAO Summit 2022: Concomitant procedures

CONNEXT


HUB
RELATED RESOURCES

Data Summary PFO closure in patients > 60 Years

Clinical insights: LAAO

Monitoring for AF prior to PFO closure

PDA Patient Guide

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline